These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 37694865)

  • 1. [An integrated approach to the treatment of pretibial myxedema based on pulse therapy with prednisolone and electrical neuromyostimulation (FREMS-therapy) in a patient with Graves' disease and thyroid eye disease].
    Perepelova MA; Zaitseva EL; Bessmertnaya EG; Grusha YO; Sviridenko NY; Galstyan GR
    Probl Endokrinol (Mosk); 2023 Aug; 69(4):32-37. PubMed ID: 37694865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Triad of exophthalmos, pretibial myxedema, and acropachy in a patient with Graves' disease.
    Anderson CK; Miller OF
    J Am Acad Dermatol; 2003 Jun; 48(6):970-2. PubMed ID: 12789197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Orbital decompression in Graves' ophthalmopathy associated with pretibial myxedema.
    Fatourechi V; Garrity JA; Bartley GB; Bergstralh EJ; Gorman CA
    J Endocrinol Invest; 1993 Jun; 16(6):433-7. PubMed ID: 8370919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pretibial myxedema as the initial manifestation of Graves' disease.
    Georgala S; Katoulis AC; Georgala C; Katoulis EC; Hatziolou E; Stavrianeas NG
    J Eur Acad Dermatol Venereol; 2002 Jul; 16(4):380-3. PubMed ID: 12224697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concurrent pretibial myxedema and thyroid eye disease following mRNA COVID-19 vaccine in a patient with history of Graves' disease.
    Caron P; Imbert P; Dekeister C; Grunenwald S
    Ann Endocrinol (Paris); 2024 Apr; 85(2):100-103. PubMed ID: 37866430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pretibial myxedema and high-dose intravenous immunoglobulin treatment.
    Antonelli A; Navarranne A; Palla R; Alberti B; Saracino A; Mestre C; Roger P; Agostini S; Baschieri L
    Thyroid; 1994; 4(4):399-408. PubMed ID: 7711502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of Graves' disease in patients with thyroid eye disease].
    Sviridenko NY; Sheremeta MS; Belovalova IM; Melnichenko GA
    Vestn Oftalmol; 2021; 137(6):128-135. PubMed ID: 34965078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Graves' disease with pretibial myxedema.
    Roenigk HH; Schermer DR
    Arch Dermatol; 1969 Jan; 99(1):117-9. PubMed ID: 5818149
    [No Abstract]   [Full Text] [Related]  

  • 9. Octreotide and Graves' ophthalmopathy and pretibial myxoedema.
    Chang TC; Kao SC; Huang KM
    BMJ; 1992 Jan; 304(6820):158. PubMed ID: 1737161
    [No Abstract]   [Full Text] [Related]  

  • 10. Lower extremity manifestations of Graves' disease.
    Sauer P; Brandes B; Mahmarian RR
    J Foot Ankle Surg; 1995; 34(5):489-97. PubMed ID: 8590885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patient with monoclonal gammopathy, thyrotoxicosis, pretibial myxedema and thyroid-associated ophthalmopathy; demonstration of direct binding of autoantibodies to the thyrotropin receptor.
    Tonacchera M; Costagliola S; Cetani F; Ducobu J; Stordeur P; Vassart G; Ludgate M
    Eur J Endocrinol; 1996 Jan; 134(1):97-103. PubMed ID: 8590966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pretibial mucin. Histologic patterns and clinical correlation.
    Somach SC; Helm TN; Lawlor KB; Bergfeld WF; Bass J
    Arch Dermatol; 1993 Sep; 129(9):1152-6. PubMed ID: 8363399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pretibial myxedema is associated with polymorphism in exon 1 of CTLA-4 gene in patients with Graves' ophthalmopathy.
    Khalilzadeh O; Mojazi Amiri H; Tahvildari M; Anvari M; Esteghamati A; Mobarra Z; Tehranchinia Z; Rashidi A; Amirzargar A
    Arch Dermatol Res; 2009 Oct; 301(10):719-23. PubMed ID: 19037649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pretibial myxedema with Graves' disease: a case report and review of Japanese literature.
    Ishizawa T; Sugiki H; Anzai S; Kondo S
    J Dermatol; 1998 Apr; 25(4):264-8. PubMed ID: 9609987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utility of rituximab treatment for exophthalmos, myxedema, and osteoarthropathy syndrome resistant to corticosteroids due to Graves' disease: a case report.
    Ferreira-Hermosillo A; Casados-V R; Paúl-Gaytán P; Mendoza-Zubieta V
    J Med Case Rep; 2018 Feb; 12(1):38. PubMed ID: 29448964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TSH receptor transcripts and TSH receptor-like immunoreactivity in orbital and pretibial fibroblasts of patients with Graves' ophthalmopathy and pretibial myxedema.
    Stadlmayr W; Spitzweg C; Bichlmair AM; Heufelder AE
    Thyroid; 1997 Feb; 7(1):3-12. PubMed ID: 9086563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral pentoxifylline and topical clobetasol propionate ointment in the treatment of pretibial myxoedema, with concomitant improvement of Graves' ophthalmopathy.
    Pineda AM; Tianco EA; Tan JB; Casintahan FA; Beloso MB
    J Eur Acad Dermatol Venereol; 2007 Nov; 21(10):1441-3. PubMed ID: 17958873
    [No Abstract]   [Full Text] [Related]  

  • 18. Localized myxedema, associated with increased serum hyaluronic acid, and response to steroid pulse therapy.
    Ohtsuka Y; Yamamoto K; Goto Y; Mizuta T; Ozaki I; Setoguchi Y; Kohda H; Sakai T
    Intern Med; 1995 May; 34(5):424-9. PubMed ID: 7647415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of pretibial myxedema (PTM) with topical steroid ointment application with sealing cover (steroid occlusive dressing technique: steroid ODT) in Graves' patients.
    Takasu N; Higa H; Kinjou Y
    Intern Med; 2010; 49(7):665-9. PubMed ID: 20371956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Euthyroid pretibial myxedema.
    Chen JJ; Ladenson PW
    Am J Med; 1987 Feb; 82(2):318-20. PubMed ID: 3812528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.